There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for Edwards Lifesciences Corporation (EW) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.41, or -0.53%, to $76.55. The Edwards Lifesciences Corporation has recorded 82,211 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that EDWARDS LIFESCIENCES TO PRESENT AT THE 2023 WELLS FARGO HEALTHCARE CONFERENCE.
This NYSE-listed company operates within the Medical Devices industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $76.96 and fluctuated between $77.16 as its day high and $75.78 as its day low. The current market capitalization of Edwards Lifesciences Corporation is $46.84B. A total of 3.4 million shares were traded on the day, compared to an average of 3.14M shares.
Insider trades can also provide insight into a stock’s future direction. During the recent three months, EW has seen 12 BUY and 17 SELL insider trades, representing the acquisition of 115,089 and the disposition of 116,166 shares. Over the last 12 months, there were 87 BUYs and 118 SELLs from insiders. Insiders purchased 1,053,380 shares during that period but sold 869,859.
In the most recent transaction, Chopra Daveen sold 8,500 shares of EW for 76.07 per share on Sep 06. After the transaction, the CVP, TMTT now owns 23,950 company shares. In a previous transaction on Sep 05, MUSSALLEM MICHAEL A sold 29,350 shares at 75.86 per share. EW shares that Director owns now total 4,486.
Among the insiders who sold shares, Ullem Scott B. disposed of 7,255 shares on Aug 31 at a per-share price of $77.79. This resulted in the CVP, Chief Financial Officer holding 19,248 shares of EW after the transaction. In another insider transaction, Chopra Daveen sold 1,500 shares at $76.69 per share on Aug 29. Company shares held by the CVP, TMTT now total 23,950.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for EW in the last 3 months, the mean price target is $97.09 with high estimates of $110.00 and low estimates of $75.00. In terms of 52-week highs and lows, EW has a high of $98.35 and a low of $67.13.
As of this writing, EW has an earnings estimate of $0.59 per share for the current quarter. EPS was calculated based on a consensus of 23 estimates, with a high estimate of $0.61 per share and a lower estimate of $0.57. The company reported an EPS of $0.62 in the last quarter, which was 1.60% higher than expectations of $0.61.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. EW’s latest balance sheet shows that the firm has $1.47B in Cash & Short Term Investments as of fiscal 2021. There were $690.30M in debt and $1.03B in liabilities at the time. Its Book Value Per Share was $10.51, while its Total Shareholder’s Equity was $5.84B.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EW is Buy with a score of 4.05.